ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

Human Genome Project publishes its final product.

October 22, 2004

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001